Face to Face Study Day
This event will start at 09:00am with the Welcome and Introductions. The study day will begin shortly after. Our expert speakers will be discussing the following topics:
Understanding Frailty in Primary Care
- Recognising frailty: Tools and assessment strategies (e.g., eFI, PRISMA-7)
- The impact of frailty on medication management and clinical decision-making
- Case studies: Early identification and intervention for at-risk patients
Polypharmacy and Deprescribing in the Frail Elderly
- Identifying inappropriate prescribing and strategies for medication review
- Deprescribing safely: A practical, patient-centered approach
- Case-based discussions: Managing multiple comorbidities in frail patients
Understanding osteoporosis and fragility fractures
- Epidemiology and impact
- Key risk factors and clinical burden
- Patient populations at higher risk
Pharmaceutical Strategies for Prevention
- Early diagnosis and risk stratification (e.g., FRAX, DXA scans)
- Role of pharmacotherapy in primary vs. secondary prevention
- Optimizing treatment adherence and persistence
- Addressing undertreatment and treatment inertia
- Managing side effects and contraindications
Innovation and Pipeline Developments
- Emerging therapies and delivery mechanisms
- Advances in personalized medicine for osteoporosis
- Role of digital tools in patient management
Case Studies / Real-World Experience
- Examples of successful pharmaceutical intervention
- Challenges in clinical practice
- Stakeholder collaboration (physicians, pharmacists, industry)
Our study days are sponsored by the pharmaceutical industry. However, the agenda for each study day is independently managed, and developed, by our clinical management team.